Is it too late to buy Macquarie Group?

A 45% rise in net profits makes this an investment opportunity you can capitalize on.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Macquarie Group (ASX: MQG) forecast yesterday that its profits for 2014 would be 40-45% higher than those recorded in FY13. This should be a pleasant surprise for shareholders, who already enjoyed a fruitful 14.4% rise in net profit (to $872 million) last year, and analysts, who were left a little underwhelmed by Macquarie's operational briefing in February.

I've been watching Macquarie for about six years, and I also expected that this year's results would provide more of the same solid, steady (though 14.4% is far from anaemic!) growth for which the investment bank is famous. Instead it seems that Macquarie was simply displaying its trademark cautious approach during its operational briefing and analysts and Foolish contributors underestimated the profit potential.

Macquarie is only up 3% on the news (which should see its profit jump from $872 million to at least ~$1.2 billion), which leaves investors with a window of golden opportunity. Macquarie pays a dividend of 4.2% at its current price, which is reasonable, and higher than competitors Magellan Financial Group (ASX: MFG), Challenger Limited (ASX: CGF) and Perpetual Limited (ASX: PPT), who each pay around 3.6%. Macquarie also has the advantage of size, experience and brand power over these smaller, equally successful fund managers.

Sharemarket analyst Morningstar estimates fair value for the investment bank to be around $57, which is roughly the price that Macquarie closed on yesterday. I would expect to see a meaningful increase in dividends this year however, which could leave investors with a higher yield than 4.2% at today's price.

Foolish takeaway

Macquarie is a share that belongs in every investor's portfolio, for the trifecta of security, regular and reliable income, and earnings growth. Often investors like myself forget that slim years for banks lead to productivity, 'right-sizing', marketing and various other improvements, which then allow the company to massively boost its profits once various segments of the market start to move again. Macquarie looks to have done just that, and in a few years could well be headed back to its all-time high of above $80 – there's a reason it got there in the first place.

Motley Fool contributor Sean O’Neill owns shares in Challenger Limited.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »